Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Camurus AB (CAMX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
498.20 +1.80    +0.36%
06:59:57 - Closed. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  SE0007692850 
S/N:  57623618
  • Volume: 12,554
  • Bid/Ask: 498.20 / 498.20
  • Day's Range: 493.20 - 500.00
Camurus AB 498.20 +1.80 +0.36%

ST:CAMX Financials

 
A brief overview of the ST:CAMX financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Camurus AB over time.

Camurus AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 1,716.85 million compared to SEK 956.34 million a year ago. Net income was SEK 431.44 million compared to SEK 55.55 million a year ago. Basic earnings per share from continuing operations was SEK 7.78 compared to SEK 1.01 a year ago. Diluted earnings per share from continuing operations was SEK 7.5 compared to SEK 0.97 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CAMX Income Statement

Gross margin TTM 92.87%
Operating margin TTM 31.07%
Net Profit margin TTM 25.13%
Return on Investment TTM 33.2%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 374.57 383.98 674.26 284.04
Gross Profit 342 351.99 645.27 255.24
Operating Income -21.03 104.05 376.06 74.34
Net Income -15.21 86.4 301.42 58.83

CAMX Balance Sheet

Quick Ratio MRQ 3.97
Current Ratio MRQ 4.41
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.64%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 1907.82 1841.66 1773.56 1349.95
Total Liabilities 414.82 353.35 391.68 288.59
Total Equity 1493 1488.32 1381.88 1061.37

CAMX Cash Flow Statement

Cash Flow/Share TTM 10.91
Revenue/Share TTM 30.87
Operating Cash Flow  8.14%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 30.01 485.7 66.9 24.27
Cash From Investing Activities -2.38 -1.35 -4.52 -1.86
Cash From Financing Activities 11.29 16.93 2.8 -2.26
Net Change in Cash 35.99 499.76 68.26 20.29
* In Millions of SEK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CAMX Comments

Write your thoughts about Camurus AB
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tommi Nuutinen
Tommi Nuutinen Nov 11, 2020 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is my Second stock I ever bought into. it was 75SEK and it was this spring. With Biden in the WH, the opioid treatment should go on strong and continuing to be bullish, but not too much.
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Nov 11, 2020 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lokI remembered it 5$ to low, as my message on board says.
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Nov 11, 2020 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lol
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Sep 07, 2020 6:07AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this is the best stock there is right now. i boughted in march, when this stovk was 80SEK. this aint gonna dip like tech, allso, this has been the best stock for growth and clear fitire as keeping on the growth. i wanna see Buvidol be the spearhead of battling the opioid crisis. etc. I think, that Camurus will be over 500SEK, before next summer ends.
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Aug 11, 2020 3:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the best stock in its category. They have stability and a amazing growth, at the same time they have reliability and they pay taxes etc. So that in mind, BUY AND HOLD. Now I know something about this, because I'm from Finland, I have been in the opioid based care, knowing many other addicts too. This is a gamechanging and really great answer to the ongoin' opioidkrisis. This company is going to ressuffhle the markets and even be at the top in opioid treatment markets. I said I'm from Finlznd, allso because if the fact that BUVIDOL is used FIRST in here Finlsnd of all other countries, besides USA, and Sweden...I think. Anyway, soon the rest of the Europe is going to BUVIDOL allso, because, when we Finnish people see something is safe and effective, we use that thing.
Reply
1 0
Report
Tommi Nuutinen
Tommi Nuutinen Jul 15, 2020 10:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
so, buy now, ask later.
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Jul 15, 2020 10:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tomorrow well see the buvidol-effect. upupup^^^
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Jul 09, 2020 12:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Csnt wait, on 17th of yhis month i see Green
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Jun 26, 2020 2:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it will go over 1000SEK in one year.
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen Jun 26, 2020 1:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this company makes B uvidol. thats the secret.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email